How to treat drooling in patients with cerebral infarction

Today, many middle-aged and elderly individuals are more prone to ischemic stroke, a condition that remains significantly harmful to the brain. Therefore, people should proactively prevent ischemic stroke in daily life to substantially reduce its incidence and minimize brain damage. So, how is drooling treated in patients with ischemic stroke?

How to Treat Drooling in Patients with Ischemic Stroke

Drooling in ischemic stroke patients can be managed through pharmacological therapy. For patients experiencing drooling during the early phase of ischemic stroke, thrombolytic therapy or mechanical thrombectomy should be performed within 4.5–6 hours of symptom onset. Neuroprotective agents such as butylphthalide may be administered to improve microcirculation and scavenge oxygen free radicals, thereby protecting the brain. Antiplatelet aggregation drugs should also be given concurrently. If drooling results from stroke or ischemic stroke, anticoagulants—as well as medications to stabilize atherosclerotic plaques, improve cerebral circulation, and mitigate arteriosclerosis—are indicated.

For diabetic patients, strict glycemic control in daily life is essential to effectively prevent ischemic stroke. Over 80% of diabetic patients develop abnormalities in lipid metabolism, which may contribute to arteriosclerosis, hyperlipidemia, and other cardiovascular and cerebrovascular diseases. Gradually increasing blood glucose levels also elevate blood viscosity and enhance coagulability, ultimately promoting the development of ischemic stroke.

In daily life, patients should maintain a positive attitude, actively cooperate with their physicians’ treatment plans, take prescribed medications regularly and in correct dosages, and pay close attention to routine care—thus facilitating prompt clinical improvement. We hope this response has been helpful to you.